| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 3, 2025 | Mar 13, 2025 | ELUTIA INC. | Director | Buy | 92.5 | +420,000 | 4.62% | ✗ | $1.1M |
| Jan 21, 2025 | Jan 23, 2025 | Acumen Pharmaceuticals, Inc. | CFO | Sell | 25.0 | -33,266 | -12.55% | ✓ | $56.6K |
| Jan 3, 2025 | Jan 7, 2025 | Acumen Pharmaceuticals, Inc. | CFO | Sell | 91.3 | +53,565 | 25.33% | ✓ | $24.4K |
| Jan 18, 2024 | Jan 19, 2024 | Acumen Pharmaceuticals, Inc. | CFO | Sell | 48.8 | -4,242 | -1.97% | ✓ | $15.7K |
| Dec 5, 2022 | Dec 7, 2022 | ELUTIA INC. | Director | Buy | 100.0 | +735,000 | 14.84% | ✗ | $3.5M |
| Dec 8, 2021 | Dec 10, 2021 | ELUTIA INC. | Director | Buy | 95.0 | +412,735 | 9.09% | ✗ | $1.7M |
| Oct 13, 2020 | Oct 13, 2020 | ELUTIA INC. | Director | Buy | 100.0 | +438,725 | 10.70% | ✗ | $7.5M |
| Nov 8, 2019 | Nov 13, 2019 | TELA Bio, Inc. | Director | Buy | 100.0 | +86,121 | 45.97% | ✗ | $1.1M |